Baidu
map

Nature平息百年淋巴管起源争议

2015-05-22 佚名 生物通

一百多年以来,科学家们一直在为淋巴系统起源这一问题争论不休——淋巴系统是血管的一个并行系统,其充当了从免疫细胞、脂肪分子到癌细胞机体内的一切物质的通道。现在Weizmann研究所生物调控系的Karina Yaniv博士解决了这一问题。在发表于5月20日《自然》(Nature)杂志上的一项研究中,她和研究小组揭示了淋巴系统在胚胎中发挥的机制,并第一次成功在实验室中培育出了淋巴细胞。一些科学家曾宣称,

一百多年以来,科学家们一直在为淋巴系统起源这一问题争论不休——淋巴系统是血管的一个并行系统,其充当了从免疫细胞、脂肪分子到癌细胞机体内的一切物质的通道。现在Weizmann研究所生物调控系的Karina Yaniv博士解决了这一问题。在发表于5月20日《自然》(Nature)杂志上的一项研究中,她和研究小组揭示了淋巴系统在胚胎中发挥的机制,并第一次成功在实验室中培育出了淋巴细胞。

一些科学家曾宣称,淋巴系统起源于称作为成血管细胞(angioblast)的特化干细胞,而其他一些人则认为它是由存在的胚胎静脉分化产生。后一种模型最终被人们所公认。

然而随着Yaniv实验室的研究不断取得进展,事实变得清晰起来,那就是争论双方的科学家都是正确的:淋巴细胞确实是由静脉生长而成,但它们起源于静脉内包含成血管细胞的微环境。

在课题研究的初期阶段,Yaniv研究小组成员Julian Nicenboim和Guy Malkinson博士获得了发育斑马鱼胚胎的图像,斑马鱼透明的身体使得研究人员能够在数天时间内实时记录胚胎的发育。当科学家们倒放录像时,确定了淋巴系统开始形成的时间点。让他们惊讶的是,他们发现生成淋巴管的细胞全都起源于胚胎主干静脉的相同部位。在那里,科学家们发现了成血管细胞微环境,一百多年前这些细胞便被认为是淋巴管的起源,只是在后来遭到了忽视。

随后研究生Tal Lupo和Lihee Asaf参与进来完成了全面深入的遗传分析,指出了一个叫做WNT5B的基因,揭示出WNT5B是促进干细胞分化为淋巴细胞的重要因子。当博士后研究人员Yogev Sela将WNT5B添加到胚胎干细胞中时,这些细胞真的分化为了淋巴细胞——这是第一次在实验室中培育出这样的细胞。

Yaniv说:“我们从成像斑马鱼开始,最终找到了使生成淋巴细胞成为可能的一个因子。这就是发育生物学研究的美妙之处:胚胎拥有一切的答案,我们所要做的就是去观察和了解。”

除了解答淋巴细胞如何产生这一长期存在的问题,了解它的形成和发育还可以提供从转移到淋巴液的异常累积,尤其是手术后消除癌性肿瘤,有关疾病的一些重要线索.

原始出处:

J. Nicenboim, G. Malkinson, T. Lupo et al.Lymphatic vessels arise from specialized angioblasts within a venous niche.Nature, May 20, 2015.doi:10.1038/nature14425

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=59743, encodeId=1ab059e4361, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59744, encodeId=9c7159e4458, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880669, encodeId=7d2a1880669c3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 03 08:45:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26556, encodeId=84d726556a9, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Tue Jun 09 16:08:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24813, encodeId=22b9248136d, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c08106028, createdName=alicelee, createdTime=Mon May 25 12:25:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24779, encodeId=908e24e79c0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150519/IMG555B5CBF061469051.jpg, createdBy=af1f1622088, createdName=wssgxyj, createdTime=Mon May 25 00:00:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529345, encodeId=aa97152934502, content=<a href='/topic/show?id=4735659e3cf' target=_blank style='color:#2F92EE;'>#淋巴管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65973, encryptionId=4735659e3cf, topicName=淋巴管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee7311933759, createdName=amyloid, createdTime=Sun May 24 00:45:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24560, encodeId=67902456078, content=学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151006/IMG561331565601C4062.jpg, createdBy=ab301623693, createdName=dane1990, createdTime=Fri May 22 20:12:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24559, encodeId=c1f22455915, content=Zan, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73e81621958, createdName=Lindong, createdTime=Fri May 22 15:53:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24533, encodeId=67f62453361, content=牛逼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Fri May 22 11:23:00 CST 2015, time=2015-05-22, status=1, ipAttribution=)]
    2016-01-26 doctording1

    这篇文章有一定深度

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=59743, encodeId=1ab059e4361, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59744, encodeId=9c7159e4458, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880669, encodeId=7d2a1880669c3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 03 08:45:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26556, encodeId=84d726556a9, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Tue Jun 09 16:08:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24813, encodeId=22b9248136d, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c08106028, createdName=alicelee, createdTime=Mon May 25 12:25:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24779, encodeId=908e24e79c0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150519/IMG555B5CBF061469051.jpg, createdBy=af1f1622088, createdName=wssgxyj, createdTime=Mon May 25 00:00:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529345, encodeId=aa97152934502, content=<a href='/topic/show?id=4735659e3cf' target=_blank style='color:#2F92EE;'>#淋巴管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65973, encryptionId=4735659e3cf, topicName=淋巴管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee7311933759, createdName=amyloid, createdTime=Sun May 24 00:45:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24560, encodeId=67902456078, content=学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151006/IMG561331565601C4062.jpg, createdBy=ab301623693, createdName=dane1990, createdTime=Fri May 22 20:12:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24559, encodeId=c1f22455915, content=Zan, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73e81621958, createdName=Lindong, createdTime=Fri May 22 15:53:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24533, encodeId=67f62453361, content=牛逼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Fri May 22 11:23:00 CST 2015, time=2015-05-22, status=1, ipAttribution=)]
    2016-01-26 doctording1

    是一篇不错的文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=59743, encodeId=1ab059e4361, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59744, encodeId=9c7159e4458, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880669, encodeId=7d2a1880669c3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 03 08:45:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26556, encodeId=84d726556a9, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Tue Jun 09 16:08:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24813, encodeId=22b9248136d, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c08106028, createdName=alicelee, createdTime=Mon May 25 12:25:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24779, encodeId=908e24e79c0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150519/IMG555B5CBF061469051.jpg, createdBy=af1f1622088, createdName=wssgxyj, createdTime=Mon May 25 00:00:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529345, encodeId=aa97152934502, content=<a href='/topic/show?id=4735659e3cf' target=_blank style='color:#2F92EE;'>#淋巴管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65973, encryptionId=4735659e3cf, topicName=淋巴管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee7311933759, createdName=amyloid, createdTime=Sun May 24 00:45:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24560, encodeId=67902456078, content=学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151006/IMG561331565601C4062.jpg, createdBy=ab301623693, createdName=dane1990, createdTime=Fri May 22 20:12:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24559, encodeId=c1f22455915, content=Zan, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73e81621958, createdName=Lindong, createdTime=Fri May 22 15:53:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24533, encodeId=67f62453361, content=牛逼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Fri May 22 11:23:00 CST 2015, time=2015-05-22, status=1, ipAttribution=)]
    2016-05-03 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=59743, encodeId=1ab059e4361, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59744, encodeId=9c7159e4458, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880669, encodeId=7d2a1880669c3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 03 08:45:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26556, encodeId=84d726556a9, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Tue Jun 09 16:08:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24813, encodeId=22b9248136d, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c08106028, createdName=alicelee, createdTime=Mon May 25 12:25:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24779, encodeId=908e24e79c0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150519/IMG555B5CBF061469051.jpg, createdBy=af1f1622088, createdName=wssgxyj, createdTime=Mon May 25 00:00:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529345, encodeId=aa97152934502, content=<a href='/topic/show?id=4735659e3cf' target=_blank style='color:#2F92EE;'>#淋巴管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65973, encryptionId=4735659e3cf, topicName=淋巴管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee7311933759, createdName=amyloid, createdTime=Sun May 24 00:45:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24560, encodeId=67902456078, content=学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151006/IMG561331565601C4062.jpg, createdBy=ab301623693, createdName=dane1990, createdTime=Fri May 22 20:12:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24559, encodeId=c1f22455915, content=Zan, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73e81621958, createdName=Lindong, createdTime=Fri May 22 15:53:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24533, encodeId=67f62453361, content=牛逼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Fri May 22 11:23:00 CST 2015, time=2015-05-22, status=1, ipAttribution=)]
    2015-06-09 18619c0a62m

    厉害

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=59743, encodeId=1ab059e4361, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59744, encodeId=9c7159e4458, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880669, encodeId=7d2a1880669c3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 03 08:45:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26556, encodeId=84d726556a9, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Tue Jun 09 16:08:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24813, encodeId=22b9248136d, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c08106028, createdName=alicelee, createdTime=Mon May 25 12:25:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24779, encodeId=908e24e79c0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150519/IMG555B5CBF061469051.jpg, createdBy=af1f1622088, createdName=wssgxyj, createdTime=Mon May 25 00:00:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529345, encodeId=aa97152934502, content=<a href='/topic/show?id=4735659e3cf' target=_blank style='color:#2F92EE;'>#淋巴管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65973, encryptionId=4735659e3cf, topicName=淋巴管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee7311933759, createdName=amyloid, createdTime=Sun May 24 00:45:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24560, encodeId=67902456078, content=学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151006/IMG561331565601C4062.jpg, createdBy=ab301623693, createdName=dane1990, createdTime=Fri May 22 20:12:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24559, encodeId=c1f22455915, content=Zan, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73e81621958, createdName=Lindong, createdTime=Fri May 22 15:53:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24533, encodeId=67f62453361, content=牛逼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Fri May 22 11:23:00 CST 2015, time=2015-05-22, status=1, ipAttribution=)]
    2015-05-25 alicelee

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=59743, encodeId=1ab059e4361, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59744, encodeId=9c7159e4458, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880669, encodeId=7d2a1880669c3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 03 08:45:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26556, encodeId=84d726556a9, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Tue Jun 09 16:08:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24813, encodeId=22b9248136d, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c08106028, createdName=alicelee, createdTime=Mon May 25 12:25:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24779, encodeId=908e24e79c0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150519/IMG555B5CBF061469051.jpg, createdBy=af1f1622088, createdName=wssgxyj, createdTime=Mon May 25 00:00:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529345, encodeId=aa97152934502, content=<a href='/topic/show?id=4735659e3cf' target=_blank style='color:#2F92EE;'>#淋巴管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65973, encryptionId=4735659e3cf, topicName=淋巴管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee7311933759, createdName=amyloid, createdTime=Sun May 24 00:45:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24560, encodeId=67902456078, content=学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151006/IMG561331565601C4062.jpg, createdBy=ab301623693, createdName=dane1990, createdTime=Fri May 22 20:12:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24559, encodeId=c1f22455915, content=Zan, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73e81621958, createdName=Lindong, createdTime=Fri May 22 15:53:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24533, encodeId=67f62453361, content=牛逼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Fri May 22 11:23:00 CST 2015, time=2015-05-22, status=1, ipAttribution=)]
    2015-05-25 wssgxyj

    厉害

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=59743, encodeId=1ab059e4361, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59744, encodeId=9c7159e4458, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880669, encodeId=7d2a1880669c3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 03 08:45:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26556, encodeId=84d726556a9, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Tue Jun 09 16:08:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24813, encodeId=22b9248136d, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c08106028, createdName=alicelee, createdTime=Mon May 25 12:25:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24779, encodeId=908e24e79c0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150519/IMG555B5CBF061469051.jpg, createdBy=af1f1622088, createdName=wssgxyj, createdTime=Mon May 25 00:00:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529345, encodeId=aa97152934502, content=<a href='/topic/show?id=4735659e3cf' target=_blank style='color:#2F92EE;'>#淋巴管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65973, encryptionId=4735659e3cf, topicName=淋巴管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee7311933759, createdName=amyloid, createdTime=Sun May 24 00:45:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24560, encodeId=67902456078, content=学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151006/IMG561331565601C4062.jpg, createdBy=ab301623693, createdName=dane1990, createdTime=Fri May 22 20:12:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24559, encodeId=c1f22455915, content=Zan, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73e81621958, createdName=Lindong, createdTime=Fri May 22 15:53:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24533, encodeId=67f62453361, content=牛逼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Fri May 22 11:23:00 CST 2015, time=2015-05-22, status=1, ipAttribution=)]
    2015-05-24 amyloid
  8. [GetPortalCommentsPageByObjectIdResponse(id=59743, encodeId=1ab059e4361, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59744, encodeId=9c7159e4458, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880669, encodeId=7d2a1880669c3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 03 08:45:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26556, encodeId=84d726556a9, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Tue Jun 09 16:08:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24813, encodeId=22b9248136d, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c08106028, createdName=alicelee, createdTime=Mon May 25 12:25:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24779, encodeId=908e24e79c0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150519/IMG555B5CBF061469051.jpg, createdBy=af1f1622088, createdName=wssgxyj, createdTime=Mon May 25 00:00:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529345, encodeId=aa97152934502, content=<a href='/topic/show?id=4735659e3cf' target=_blank style='color:#2F92EE;'>#淋巴管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65973, encryptionId=4735659e3cf, topicName=淋巴管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee7311933759, createdName=amyloid, createdTime=Sun May 24 00:45:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24560, encodeId=67902456078, content=学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151006/IMG561331565601C4062.jpg, createdBy=ab301623693, createdName=dane1990, createdTime=Fri May 22 20:12:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24559, encodeId=c1f22455915, content=Zan, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73e81621958, createdName=Lindong, createdTime=Fri May 22 15:53:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24533, encodeId=67f62453361, content=牛逼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Fri May 22 11:23:00 CST 2015, time=2015-05-22, status=1, ipAttribution=)]
    2015-05-22 dane1990

    学习~~

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=59743, encodeId=1ab059e4361, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59744, encodeId=9c7159e4458, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880669, encodeId=7d2a1880669c3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 03 08:45:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26556, encodeId=84d726556a9, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Tue Jun 09 16:08:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24813, encodeId=22b9248136d, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c08106028, createdName=alicelee, createdTime=Mon May 25 12:25:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24779, encodeId=908e24e79c0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150519/IMG555B5CBF061469051.jpg, createdBy=af1f1622088, createdName=wssgxyj, createdTime=Mon May 25 00:00:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529345, encodeId=aa97152934502, content=<a href='/topic/show?id=4735659e3cf' target=_blank style='color:#2F92EE;'>#淋巴管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65973, encryptionId=4735659e3cf, topicName=淋巴管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee7311933759, createdName=amyloid, createdTime=Sun May 24 00:45:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24560, encodeId=67902456078, content=学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151006/IMG561331565601C4062.jpg, createdBy=ab301623693, createdName=dane1990, createdTime=Fri May 22 20:12:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24559, encodeId=c1f22455915, content=Zan, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73e81621958, createdName=Lindong, createdTime=Fri May 22 15:53:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24533, encodeId=67f62453361, content=牛逼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Fri May 22 11:23:00 CST 2015, time=2015-05-22, status=1, ipAttribution=)]
    2015-05-22 Lindong

    Zan

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=59743, encodeId=1ab059e4361, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59744, encodeId=9c7159e4458, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 16:49:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880669, encodeId=7d2a1880669c3, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue May 03 08:45:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26556, encodeId=84d726556a9, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Tue Jun 09 16:08:00 CST 2015, time=2015-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24813, encodeId=22b9248136d, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c08106028, createdName=alicelee, createdTime=Mon May 25 12:25:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24779, encodeId=908e24e79c0, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150519/IMG555B5CBF061469051.jpg, createdBy=af1f1622088, createdName=wssgxyj, createdTime=Mon May 25 00:00:00 CST 2015, time=2015-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529345, encodeId=aa97152934502, content=<a href='/topic/show?id=4735659e3cf' target=_blank style='color:#2F92EE;'>#淋巴管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65973, encryptionId=4735659e3cf, topicName=淋巴管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee7311933759, createdName=amyloid, createdTime=Sun May 24 00:45:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24560, encodeId=67902456078, content=学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151006/IMG561331565601C4062.jpg, createdBy=ab301623693, createdName=dane1990, createdTime=Fri May 22 20:12:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24559, encodeId=c1f22455915, content=Zan, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73e81621958, createdName=Lindong, createdTime=Fri May 22 15:53:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24533, encodeId=67f62453361, content=牛逼!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Fri May 22 11:23:00 CST 2015, time=2015-05-22, status=1, ipAttribution=)]
    2015-05-22 2015520llm

    牛逼!

    0

相关资讯

Leukemia:慢性淋巴细胞性白血病患者的潜在新疗法

最近,随着一项新治疗策略的发展,慢性淋巴细胞性白血病(CLL)患者的长期生存时间有望得以增加。由澳大利亚莫纳什大学免疫学系教授Fabienne Mackay和博士研究生Damien Saulep-Easton带领的一项开拓性研究,最近发表在白血病领域的权威杂志 Leukemia ,解开了CLL从未报道过的一面。 慢性淋巴细胞白血病是一种影响B淋巴细胞系的恶性肿瘤,它的特点是产生大量不成熟的淋

CSMO 2014:朱军教授谈抗CD19 CART细胞在B细胞淋巴瘤中的临床应用

非霍奇金淋巴瘤是一类起源于B细胞或T细胞的淋巴系统恶性肿瘤,其中B细胞来源的淋巴瘤约占60-70%。尽管以利妥昔单抗为代表的单克隆抗体使B细胞淋巴瘤的预后有了很大改善,但仍有部分患者会复发耐药。GELA LNH-98.5研究随访10年的结果提示,弥漫大B细胞淋巴瘤(DLBCL)患者一线接受R-CHOP方案治疗后约40%的患者会复发。而B细胞淋巴瘤中第二常见的滤泡淋巴瘤(FL)至今多数

Nature:B淋巴细胞研究 风风雨雨50年

该成果所产生的影响再怎么高估都不为过。在接下来的几年里,单克隆抗体遍布实验生物学的所有角落。 B淋巴细胞的扫描电镜照片 图片来源:Eye of Science/SPL 1963年,当Max Dale Cooper加入Robert Good在美国明尼苏达大学的实验室时,免疫学领域出现了两个阵营。它们彼此都非常不喜欢对方。 当时,免疫学研究的核心问题是脊椎动物如何调整自己的防线以应对细

Nature:科学家首次证实肠道细菌能显著影响B细胞发育

日前,来自波士顿儿童医院(Boston Children’s Hospital)的研究人员发现,肠道细菌显著地影响了免疫系统的 B 淋巴细胞。尽管此前有研究证实,肠道细菌对于 T 淋巴细胞的影响,而这是研究人员首次证实微生物影响了肠道 B 细胞的早期发育。【原文下载】 刚出生时,免疫系统编程未成熟 B 细胞,通过将编码不同抗体元件的基因洗牌,使之生成能够对抗大量潜在致病抗原的抗体。这一洗

Nutrition:母亲维生素A的摄入对后代抗体形成的影响

B淋巴细胞的祖细胞存在于胎儿肝脏的造血细胞岛中,此后B淋巴细胞的产生和分化场所逐渐被骨髓所代替。B淋巴细胞简称B细胞,成熟的B细胞主要定居于淋巴结皮质浅层的淋巴小结和脾脏的红髓和白髓的淋巴小结内。B细胞在抗原刺激下可分化为浆细胞,浆细胞可合成和分泌抗体(免疫球蛋白),主要执行机体的体液免疫。B1淋巴细胞源自胎儿的生命早期,能产生最自然的抗体(NAb)。维生素A调节早期淋巴细胞增殖。先前有动物试验证

JCO:儿童急性淋巴细胞白血病患者脑体积存在减少趋势

在2013年4月15日在线出版的《临床肿瘤学杂志》(Journal of Clinical Oncology)上,挪威奥斯陆大学Bernward Zeller博士等人发表了一项研究结果,该研究针对曾于儿童期患有急性淋巴细胞白血病(ALL)的成年长期幸存者与健康对照人群,旨在对这些人群的局部脑容量进行比较。 该研究考察了130例儿童ALL幸存者,这些患者曾于1970年至2002年期间,经核磁共振成

Baidu
map
Baidu
map
Baidu
map